Sign in

Adar1 Capital Management, LLC

CIK:0001940272
Hedge Fund
$820M AUM
210 holdings
Austin, TX, United States
Founded:2022
9 employees
Latest filing:Jun 30, 2025

ADAR1 Capital Management, LLC is a Texas-based investment advisory firm founded and managed by Dr. Daniel Schneeberger. Headquartered in Austin, TX, the firm manages capital on behalf of investment partnerships and institutional clients. As of the most recent filings, the firm is relatively small, with an employee count under 10, and focuses primarily on public equity market strategies. Their ownership structure centers on Dr. Schneeberger and related entities.

Investment Strategy

ADAR1 Capital Management, LLC employs long/short equity strategies, with a focus on both public equity and related derivatives in the healthcare, biotechnology, and technology sectors. The firm appears to use fundamental analysis to identify both undervalued long opportunities and positions for short-selling, frequently involving event-driven and special situation investments. The firm also engages in concentrated positions when it perceives compelling risk/reward dynamics.

Top Buys
K
KROSKEROS THERAPEUTICS INC
+$56.8M
P
PRTAPROTHENA CORP PLC
+$20.5M
S
SPYSPDR S&P 500 ETF TR
+$14.0M
A
ABVXABIVAX SA
+$9.7M
C
CTMXCYTOMX THERAPEUTICS INC
+$7.0M
Top Sells
R
ROIVROIVANT SCIENCES LTD
-$13.3M
S
SWTXSPRINGWORKS THERAPEUTICS INC
-$8.0M
I
IMVTIMMUNOVANT INC
-$8.0M
R
RAPTRAPT THERAPEUTICS INC
-$7.3M
I
ITCIINTRA-CELLULAR THERAPIES INC
-$6.3M

Top Holdings

K
KROSKEROS THERAPEUTICS INC
+11.0%$71.9M
P
PTGXPROTAGONIST THERAPEUTICS INC
+8.0%$52.4M
B
BOXXEA SERIES TRUST
+5.8%$38.0M
Z
ZLABZAI LAB LTD
+4.6%$29.7M
A
ABVXABIVAX SA
+3.6%$23.5M

Equity Positions (187)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
K
KROS
KEROS THERAPEUTICS INC11.03%$71.9M5,389,264$12.61$13.35+$56.8M
P
PTGX
PROTAGONIST THERAPEUTICS INC8.04%$52.4M948,069$31.64$55.27+$7.0M
B
BOXX
EA SERIES TRUST5.83%$38.0M337,125$106.83$112.68+$401.2K
Z
ZLAB
ZAI LAB LTD4.56%$29.7M850,437$25.19$34.97-$4.3M
A
ABVX
ABIVAX SA3.60%$23.5M3,071,340$7.90$7.65+$9.7M

Options Positions (8)

TickerSecurityActionTypeNotional ValueContractsUnderlying PricePremium PaidChange (Contracts)Change (Value)
S
SPY
SPDR S&P 500 ETF TRNew
Put
$25.0M405$617.85$617.85+405+$25.0M
J
JANX
JANUX THERAPEUTICS INC
Call
$6.1M2,649$23.10$27.000-$1.0M
S
SMMT
SUMMIT THERAPEUTICS INC
Call
$2.1M1,000$21.28$19.290+$199.0K
S
SRPT
SAREPTA THERAPEUTICS INCNew
Call
$940.5K550$17.10$17.10+550+$940.5K
N
NKTR
NEKTAR THERAPEUTICSNew
Put
$904.4K350$25.84$25.84+350+$904.4K

Industry Allocation

PHARMACEUTICAL PREPARATIONS
+67.4%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+10.2%
BLANK CHECKS
+4.7%
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
+0.5%
SERVICES-MEDICAL LABORATORIES
+0.4%